Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

432
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
432
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

1.3K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.3K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

871
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
871
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

4.8K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.8K
Flail Chest-II01:26

Flail Chest-II

713
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
713
Pneumothorax-II01:27

Pneumothorax-II

1.1K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recommendations for the management of bone demineralization in cystic fibrosis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2008
Same author

Efficacy of intravenous spiramycin in the treatment of severe Legionnaires' disease.

The Journal of antimicrobial chemotherapy·1988
Same author

[Strangulated obturator hernia with myonecrosis of the thigh].

Presse medicale (Paris, France : 1983)·1987
Same author

[Significance of the presence of Candida sp. in bronchopulmonary secretions. Contribution of pulmonary biopsy].

Annales de biologie clinique·1987
Same author

[Respiratory infections in AIDS].

La Revue du praticien·1986

Related Experiment Video

Updated: Feb 23, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

1.6K

[Dantrolene-induced pleurisy: a case report].

F Dohen1, V Montagne, E Lelieur

  • 1Service de Pneumologie, Centre Hospitalier de Dunkerque 130, avenue Louis Herbeaux, B.P. 6.367, 59385 Dunkerque Cedex.

Revue De Pneumologie Clinique
|October 18, 2000
PubMed
Summary

Dantrolene, a muscle relaxant, can rarely cause lung toxicity. This report details drug-induced pleurisy, a rare side effect of dantrolene, often resolving after medication cessation.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Toxicology

Background:

  • Dantrolene is a muscle relaxant for spasticity.
  • It is known for liver toxicity.
  • Lung toxicity is a rare adverse effect.

Observation:

  • A patient developed pleurisy after chronic dantrolene use.
  • This drug-induced pleural reaction was associated with pleural and peripheral eosinophilia.

Findings:

  • Six cases of dantrolene-induced pleurisy after >60 days of use are documented.
  • Pleurisy typically shows spontaneous regression post-dantrolene withdrawal.
  • Radiological cure is usually observed within months.

Implications:

  • This highlights a rare but significant pulmonary complication of dantrolene.

More Related Videos

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage
07:29

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage

Published on: August 31, 2022

2.2K
Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

5.5K

Related Experiment Videos

Last Updated: Feb 23, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

1.6K
Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage
07:29

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage

Published on: August 31, 2022

2.2K
Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

5.5K

  • Early recognition and drug withdrawal are crucial for patient recovery.
  • Further research is needed to elucidate the mechanism of this adverse reaction.